Category
Drug Product CDMOs
Compare drug product CDMOs for formulation development, solid oral dosage, sterile injectables, and specialty dosage forms. Filter by dosage type, scale, and certifications.
1365 companies listed
About Drug Product Manufacturing
Drug product manufacturing transforms active pharmaceutical ingredients into the finished dosage forms patients use. This includes solid oral dosage (tablets, capsules), sterile injectables (vials, pre-filled syringes), semi-solids (creams, gels), and specialty forms (transdermal patches, inhalers, implants).
Formulation development is where science meets engineering. A CDMO's formulation team determines bioavailability, stability, and manufacturability. For poorly soluble compounds, techniques like spray drying, hot melt extrusion, and nano-milling can be the difference between a viable product and a failed program. Ask for specific experience with your compound class.
What scale do you need? Clinical-phase drug product often runs in batches of 5,000-50,000 units. Commercial scale might mean millions of units per month. Few CDMOs cover the full range efficiently. Match your current and projected volumes to a CDMO with the right equipment and batch size flexibility.
Companies (1365)
Interos Inc.
France
Interos Inc. is a supply chain risk management software company that uses AI and automation to map, monitor, and assess supply chain resilience. The platform helps Fortune 1000 companies and federal agencies (including the U.S. Department of Defense and NASA) identify and mitigate supply chain disruptions. Interos does not manufacture pharmaceutical products.
InVitria (Ventria Bioscience)
United States
InVitria develops and manufactures recombinant, animal-origin-free proteins for biomanufacturing and final formulation. Products include recombinant human serum albumin, transferrin, and lysozyme used in cell culture media for gene therapy, cell therapy, vaccine production, antibody production, and T-cell immunotherapy. InVitria's products are incorporated in 30 on-market products including 11 therapeutics, serving 1,000+ customers across 40+ countries.
Frequently Asked Questions
What is drug product manufacturing?+
Drug product manufacturing converts APIs into final dosage forms for patients. The process includes formulation development (choosing excipients, optimizing bioavailability), process development (granulation, compression, coating, filling), analytical method development, stability testing, and scale-up to commercial volumes. It also covers packaging and labeling.
What dosage forms can drug product CDMOs produce?+
Common dosage forms include tablets (immediate-release, modified-release, orally disintegrating), capsules (hard gelatin, HPMC, softgel), sterile injectables (lyophilized, liquid), semi-solids (creams, ointments, gels), liquids (solutions, suspensions, syrups), and specialty forms (transdermal patches, inhalers, suppositories, implants). Most CDMOs specialize in 2-3 dosage forms rather than offering all.
Need help finding the right CDMO?
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
